Here is the latest shareholding Pattern of CELESTIAL BIOLABS. For more details, see the CELESTIAL BIOLABS financial fact sheet and CELESTIAL BIOLABS share price.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | 26.07 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 0.00 | 4.61 | 4.61 | 4.61 | 4.61 | 4.60 | 4.60 | 4.51 | |
Individuals | % | 64.94 | 62.01 | 62.08 | 62.09 | 63.25 | 63.28 | 63.27 | 63.31 | |
NRIs/OCBs | % | 0.00 | 4.21 | 4.15 | 4.15 | 2.99 | 3.00 | 3.00 | 3.02 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 8.99 | 3.10 | 3.09 | 3.08 | 3.08 | 3.05 | 3.06 | 3.09 | |
Total Non-Institution | % | 73.93 | 73.93 | 73.93 | 73.93 | 73.93 | 73.93 | 73.93 | 73.93 | |
Total Public | % | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ADANI ENTERPRISES ZOMATO ADANI PORTS & SEZ ADANI TOTAL GAS APOLLO HOSPITALS
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.